Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J van Gool

Showing results (111-120 of 137) with videos related to

Pageof 14
Sort By:
Clinical Chemistry and Laboratory Medicine|October 12, 2023
M-protein diagnostics in multiple myeloma patients using ultra-sensitive targeted mass spectrometry and an off-the-shelf calibratorCharissa Wijnands, Pieter Langerhorst, Somayya Noori, et al.
Nature Reviews. Drug Discovery|April 29, 2017
Bridging the translational innovation gap through good biomarker practiceAlain J van Gool, Florence Bietrix, Eric Caldenhoven, et al.
Journal of Proteome Research|October 23, 2009
The effect of preanalytical factors on stability of the proteome and selected metabolites in cerebrospinal fluid (CSF)Therese Rosenling, Christiaan L Slim, Christin Christin, et al.
Journal of Clinical Medicine|September 22, 2020
Plasma C-Peptide and Risk of Developing Type 2 Diabetes in the General PopulationSara Sokooti, Lyanne M Kieneker, Martin H de Borst, et al.
Cell|May 2, 1997
Defective transcription-coupled repair in Cockayne syndrome B mice is associated with skin cancer predispositionG T van der Horst, H van Steeg, R J Berg, et al.
The Journal of Clinical Endocrinology and Metabolism|December 19, 2022
Circulating FGF21 Concentration, Fasting Plasma Glucose, and the Risk of Type 2 Diabetes: Results From the PREVEND StudyAdrian Post, Wendy A Dam, Sara Sokooti, et al.
Mutation Research|August 8, 1996
A CHO mutant, UV40, that is sensitive to diverse mutagens and represents a new complementation group of mitomycin C sensitivityD B Busch, M Z Zdzienicka, A T Natarajan, et al.
Gigascience|January 13, 2024
A multi-omics data analysis workflow packaged as a FAIR Digital ObjectAnna Niehues, Casper de Visser, Fiona A Hagenbeek, et al.
Metabolites|September 26, 2021
Metabolomics-Based Screening of Inborn Errors of Metabolism: Enhancing Clinical Application with a Robust Computational PipelineBrechtje Hoegen, Alan Zammit, Albert Gerritsen, et al.
Clinical Chemistry and Laboratory Medicine|February 9, 2024
N-linked glycosylation of the M-protein variable region: glycoproteogenomics reveals a new layer of personalized complexity in multiple myelomaPieter Langerhorst, Melissa Baerenfaenger, Purva Kulkarni, et al.
Pageof 14

Showing results (111-120 of 137) with videos related to

Sort By:
Pageof 14
Clinical Chemistry and Laboratory Medicine|October 12, 2023
M-protein diagnostics in multiple myeloma patients using ultra-sensitive targeted mass spectrometry and an off-the-shelf calibratorCharissa Wijnands, Pieter Langerhorst, Somayya Noori, et al.
Nature Reviews. Drug Discovery|April 29, 2017
Bridging the translational innovation gap through good biomarker practiceAlain J van Gool, Florence Bietrix, Eric Caldenhoven, et al.
Journal of Proteome Research|October 23, 2009
The effect of preanalytical factors on stability of the proteome and selected metabolites in cerebrospinal fluid (CSF)Therese Rosenling, Christiaan L Slim, Christin Christin, et al.
Journal of Clinical Medicine|September 22, 2020
Plasma C-Peptide and Risk of Developing Type 2 Diabetes in the General PopulationSara Sokooti, Lyanne M Kieneker, Martin H de Borst, et al.
Cell|May 2, 1997
Defective transcription-coupled repair in Cockayne syndrome B mice is associated with skin cancer predispositionG T van der Horst, H van Steeg, R J Berg, et al.
The Journal of Clinical Endocrinology and Metabolism|December 19, 2022
Circulating FGF21 Concentration, Fasting Plasma Glucose, and the Risk of Type 2 Diabetes: Results From the PREVEND StudyAdrian Post, Wendy A Dam, Sara Sokooti, et al.
Mutation Research|August 8, 1996
A CHO mutant, UV40, that is sensitive to diverse mutagens and represents a new complementation group of mitomycin C sensitivityD B Busch, M Z Zdzienicka, A T Natarajan, et al.
Gigascience|January 13, 2024
A multi-omics data analysis workflow packaged as a FAIR Digital ObjectAnna Niehues, Casper de Visser, Fiona A Hagenbeek, et al.
Metabolites|September 26, 2021
Metabolomics-Based Screening of Inborn Errors of Metabolism: Enhancing Clinical Application with a Robust Computational PipelineBrechtje Hoegen, Alan Zammit, Albert Gerritsen, et al.
Clinical Chemistry and Laboratory Medicine|February 9, 2024
N-linked glycosylation of the M-protein variable region: glycoproteogenomics reveals a new layer of personalized complexity in multiple myelomaPieter Langerhorst, Melissa Baerenfaenger, Purva Kulkarni, et al.
Pageof 14